RxDoctor Payments Data

Joyce Rabbat, MD

Allergy & Immunology · Maywood, ILNPI 1144486416

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $55,340 of the $78,840 with a category attached, or 70.2%. ARS Pharmaceuticals Operations, Inc. accounts for 74.5% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $58,855, more than ten times the $424 reported in 2022. Among allergy & immunology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,840in general payments, 2019–2025

Across 77 payments — averaging $1023.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ARS Pharmaceuticals Operations, Inc.$59K
  • Kaleo, Inc.$19K
  • Sanofi$257
  • Teva Pharmaceuticals USA, Inc.$124
  • AstraZeneca$122
  • Tolmar, Inc.$108
  • plus $294 from 3 others

What the payments were for

  • Consulting fees$4,3285%
  • Speaking & faculty fees$55,34070%
  • Travel & lodging$16,56821%
  • Food & beverage$2,6053%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,840 in reported general payments places this provider in the 90th percentile of 161 allergy & immunology providers in Illinois.

See all allergy & immunology providers in Illinois

Medicare billing

Part B allowed, 2024
$4,560
Medicare patients
25
Services billed
123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XolairOmalizumab28$157,447
Dupixent PenDupilumab19$59,040
SymbicortBudesonide/Formoterol Fumarate27$7,209
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$2,935
Azelastine Hcl14$923
Fluticasone Propionate23$311
Montelukast Sodium38$260
Famotidine11$56

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaSymbicort$122$7,20927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 161 allergy & immunology providers in Illinois.

Other allergy & immunology in Maywood

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →